Menu
Search
|

Menu

Close
X

Laboratory Corporation of America Holdings LH.N (New York Stock Exchange)

154.11 USD
-1.85 (-1.19%)
As of Mar 20
chart
Previous Close 155.96
Open 155.58
Volume 111,167
3m Avg Volume 231,875
Today’s High 155.94
Today’s Low 153.34
52 Week High 190.35
52 Week Low 119.38
Shares Outstanding (mil) 98.60
Market Capitalization (mil) 15,195.25
Forward P/E 17.04
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.30 Mean rating from 20 analysts

KEY STATS

Revenue (mm, USD)
FY18
11,333
FY17
10,308
FY16
9,642
EPS (USD)
FY18
9.045
FY17
6.815
FY16
7.016
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
17.04
58.80
Price to Sales (TTM)
vs sector
1.34
8.99
Price to Book (MRQ)
vs sector
2.19
4.66
Price to Cash Flow (TTM)
vs sector
10.26
40.60
Total Debt to Equity (MRQ)
vs sector
86.92
17.49
LT Debt to Equity (MRQ)
vs sector
86.67
13.83
Return on Investment (TTM)
vs sector
6.46
12.11
Return on Equity (TTM)
vs sector
13.48
13.22

EXECUTIVE LEADERSHIP

David King
Chairman of the Board, President, Chief Executive Officer, Since 2009
Salary: $1,150,000.00
Bonus: $1,960,370.00
Glenn Eisenberg
Chief Financial Officer, Executive Vice President, Since 2014
Salary: $666,474.00
Bonus: $746,219.00
John Ratliff
Chief Executive Officer - Covance Drug Development, Since
Salary: $659,750.00
Bonus: $648,415.00
Lisa Uthgenannt
Chief Human Resource Officer, Since 2015
Salary: $440,171.00
Bonus: $318,912.00
Edward Dodson
Senior Vice President, Chief Accounting Officer, Principal Accounting Officer, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Healthcare Facilities & Services
Address:

358 S MAIN ST
BURLINGTON   NC   27215-5837

Phone: +1336.2291127

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

SPONSORED STORIES